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Abstract: We report a case of progressive multifocal leukoencephalopathy developing in a 
ﬂ  udarabine-naïve patient with chronic lymphocytic leukemia. We suggest that progressive 
multifocal leukoencephalopathy should be considered in any chronic lymphocytic leukemia 
patient with unexplained neurological symptoms. Treatment history does not necessarily require 
ﬂ  udarabine. Intrathecal cytosine arabinoside although unsuccessful in this patient, is a therapeutic 
option to consider in patients experiencing side effects from systemic therapy.
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Case report
A 55-year-old Caucasian man presented with progressive visual impairment. He had 
difﬁ  culty in following words on a printed page and was ‘jumping from one line to 
the next’. This was associated with occipital headaches. He had no other neurological 
symptoms. Neurological examination was normal.
Past medical history was signiﬁ  cant for chronic lymphocytic leukemia (CLL) diag-
nosed 15 years ago. Since his diagnosis he had received several courses of chlorambucil 
and corticosteroids with good response each time. In fact, he received three courses 
of chlorambucil and prednisolone in the year prior to these visual symptoms. There 
was no signiﬁ  cant other past medical history or family history. Magnetic resonance 
imaging (MRI) of the brain revealed a lesion in the occipital lobe. Other investiga-
tions including repeated cerebrospinal ﬂ  uid analysis were not conclusive. The patient 
refused a brain biopsy.
Three months later, the patient’s vision was progressively worsening with new 
dysarthria and weakness of his right arm and right leg affecting his gait and balance. 
The patient ﬁ  nally consented and a stereotactic brain biopsy of the lesion in the occipital 
lobe was carried out.
The biopsy showed myelin loss and astrocytic atypia with occasional inclusions 
(Figures 1 and 2). Immunohistochemistry was positive for John Cunningham (JC) virus 
with the COL-5 strain antibody. In-situ hybridization for JC virus was positive. These 
ﬁ  ndings are diagnostic of progressive multifocal leukoencephalopathy (PML).
Therapy for PML was then commenced. He was initially started on intravenous 
cidoﬁ  vir. After two courses, his neurologic signs continued to progress through 
treatment and he was switched to intravenous cytosine arabinoside 2 mg/kg per day 
for ﬁ  ve days as described by Aksamit.1 He received two cycles of intravenous cyto-
sine arabinoside, but this was complicated by neutropenic sepsis from the systemic 
therapy. He was then switched to intrathecal liposomal cytarabine (x one cycle). The 
rationale for the intrathecal therapy was to deliver treatment directly to the central International Journal of General Medicine 2009:2 6
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Figure 1 Brain biopsy showing changes suggestive of PML and large abnormally hypertrophied reactive astrocytes are visible.
Figure 2 The large hypertrophied astrocytes stain positive with glial ﬁ  brillary acidic protein.International Journal of General Medicine 2009:2 7
Progressive multifocal leukoencephalopathy
nervous system and minimize systemic toxicity. There was 
progressive deterioration despite treatment; the patient was 
unable to communicate and was paraplegic. The decision to 
discontinue further treatment was made in conjunction with 
the family and he died six months later.
Discussion
Opportunistic infections are a major cause of morbidity and 
mortality in CLL patients. It is estimated that up to 80% of CLL 
patients will develop infectious complications at some time in 
their disease course, with infections accounting for up to 60% 
of deaths.2 The pathogenesis of infection in CLL patients is 
multifactorial, involving a variety of immune defects inherent 
to the disease process and further inﬂ  uenced by disease stage 
and subsequent therapy with immunosuppressive agents.
PML is an opportunistic viral infection resulting from 
impaired cell mediated immune response. It is caused by either 
a primary infection or a secondary reactivation in the brain 
oligodendrocytes of the JC virus. Thus PML has been ﬁ  rst 
recognized as a late complication of various chronic diseases 
such as leukemia, lymphoma, sarcoidosis, and carcinomatosis. 
With increasing use of immunosuppressive agents in the 
treatment of autoimmune diseases and organ transplantation, 
PML has also appeared in these settings. HIV infection has 
become the major risk factor for the development of PML due 
to acquired impairment of cell-mediated immunity.
There is no causal link with a speciﬁ  c immunosuppres-
sant drug. Corticosteroids, cyclophosphamide, chlorambucil, 
azathioprine and cyclosporin A have all been associated 
with the occurrence of PML in case reports in the setting 
of rheumatologic and hematologic malignancy. There have 
been many case reports published linking PML with CLL. 
The therapeutic agents used in most cases described used 
combination chemotherapy and/or ﬂ  udarabine.
There are only two other cases, similar to our case, 
reported that associate treatment with alkylating agents alone 
with PML.3,4 There are two additional cases that are not 
associated with any treatment.5,6 The fact that these patients 
had no previous treatment lends support to the fact that CLL 
is by itself immunosuppressive as a disease process.
There is no data in the literature on the signiﬁ  cance of 
the interval between diagnosis of CLL and presentation of 
PML. It could be speculated that the longer the duration 
of immunosuppression, the higher the risk that the JC virus 
will be reactivated.
No effective treatment is available at present. Anecdotal 
reports show some efﬁ  cacy of cidofovir, interferon alfa, 
and cytosine arabinoside. The median survival for PML in 
combination with CLL is 4.3 months.7
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